{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T22:25:52Z","timestamp":1793485552846,"version":"4.5.0"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gut microbiome dysbiosis has been implicated in various gastrointestinal and extra-gastrointestinal diseases, but evidence on the efficacy and safety of fecal microbiota transplantation (FMT) for therapeutic indications remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The gutMDisorder database was used to summarize the associations between gut microbiome dysbiosis and diseases. We performed an umbrella review of published meta-analyses to determine the evidence synthesis on the efficacy and safety of FMT in treating various diseases. Our study was registered in PROSPERO (CRD42022301226).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Gut microbiome dysbiosis was associated with 117 gastrointestinal and extra-gastrointestinal. Colorectal cancer was associated with 92 dysbiosis. Dysbiosis involving\n                      <jats:italic>Firmicutes<\/jats:italic>\n                      (phylum) was associated with 34 diseases. We identified 62 published meta-analyses of FMT. FMT was found to be effective for 13 diseases, with a 95.56% cure rate (95% CI: 93.88\u201397.05%) for recurrent\n                      <jats:italic>Chloridoids difficile<\/jats:italic>\n                      infection (rCDI). Evidence was high quality for rCDI and moderate to high quality for ulcerative colitis and Crohn\u2019s disease but low to very low quality for other diseases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Gut microbiome dysbiosis may be implicated in numerous diseases. Substantial evidence suggests FMT improves clinical outcomes for certain indications, but evidence quality varies greatly depending on the specific indication, route of administration, frequency of instillation, fecal preparation, and donor type. This variability should inform clinical, policy, and implementation decisions regarding FMT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2023.1286429","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T06:27:01Z","timestamp":1698992821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review"],"prefix":"10.3389","volume":"14","author":[{"given":"Xianzhuo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaolong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/antibiotics12050868","article-title":"Future modulation of gut microbiota: from Eubiotics to FMT, engineered bacteria, and phage therapy","volume":"12","author":"Airola","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0140-6736(19)31266-8","article-title":"The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications","volume":"394","author":"Allegretti","year":"2019","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","article-title":"Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach","volume":"13","author":"Aromataris","year":"2015","journal-title":"Int. J. Evid. Based Healthc."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"100642","DOI":"10.1016\/j.eclinm.2020.100642","article-title":"Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an updated systematic review and meta-analysis","author":"Baunwall","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jhin.2015.10.024","article-title":"Adverse events in faecal microbiota transplant: a review of the literature","volume":"92","author":"Baxter","year":"2016","journal-title":"J. Hosp. Infect."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2011.244","article-title":"Fecal microbiota transplantation and emerging applications","volume":"9","author":"Borody","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12876-018-0860-5","article-title":"Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection","volume":"18","author":"Brown","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"26191","DOI":"10.3402\/mehd.v26.26191","article-title":"Dysbiosis of the gut microbiota in disease","volume":"26","author":"Carding","year":"2015","journal-title":"Microb. Ecol. Health Dis."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1038\/s41467-022-30857-9","article-title":"Short- and long-read metagenomics expand individualized structural variations in gut microbiomes","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/ecco-jcc\/jjy031","article-title":"Effect of faecal microbiota transplantation for treatment of Clostridium difficile infection in patients with inflammatory bowel disease: a systematic review and meta-analysis of cohort studies","volume":"12","author":"Chen","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"D554","DOI":"10.1093\/nar\/gkz843","article-title":"gutMDisorder: a comprehensive database for dysbiosis of the gut microbiota in disorders and interventions","volume":"48","author":"Cheng","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"175628482110410","DOI":"10.1177\/17562848211041004","article-title":"Systematic review with meta-analysis: encapsulated faecal microbiota transplantation - evidence for clinical efficacy","volume":"14","author":"Cold","year":"2021","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"De Vos","year":"2022","journal-title":"Gut"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40121-020-00356-9","article-title":"Fecal microbiota transplantation may be the best option in treating multiple Clostridioides difficile infection: a network meta-analysis","volume":"10","author":"Dembrovszky","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1080\/07853890.2021.1927170","article-title":"Is there a role of faecal microbiota transplantation in reducing antibiotic resistance burden in gut? A systematic review and meta-analysis","volume":"53","author":"Dharmaratne","year":"2021","journal-title":"Ann. Med."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/SGA.0000000000000652","article-title":"Efficacy of Fecal microbiota transplantation in irritable bowel syndrome patients: an updated systematic review and meta-analysis","volume":"45","author":"Elhusein","year":"2022","journal-title":"Gastroenterol. Nurs."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jclinepi.2017.08.010","article-title":"Living systematic review: 1. Introduction-the why, what, when, and how","volume":"91","author":"Elliott","year":"2017","journal-title":"J. Clin. Epidemiol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e25390","DOI":"10.1097\/MD.0000000000025390","article-title":"The combined therapy of fecal microbiota transplantation and laxatives for functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"100","author":"Fang","year":"2021","journal-title":"Medicine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e070849","DOI":"10.1136\/bmj-2022-070849","article-title":"Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement","volume":"378","author":"Gates","year":"2022","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1854640","article-title":"Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis","volume":"12","author":"Green","year":"2020","journal-title":"Gut Microbes"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0140-6736(03)12489-0","article-title":"Gut flora in health and disease","volume":"361","author":"Guarner","year":"2003","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.13381\/j.cnki.cjm.202101005","article-title":"The effects of frozen fecal microbiota transplantation on C. difficile-related diarrhea: a meta-analysis","volume":"33","author":"Han","year":"2021","journal-title":"Chin. J. Microecol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cmet.2021.05.005","article-title":"Fecal microbiota transplantation in human metabolic diseases: from a murky past to a bright future?","volume":"33","author":"Hanssen","year":"2021","journal-title":"Cell Metab."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1182\/blood-2021-151904","article-title":"Fecal microbiota transplantation as a therapeutic option for graft-versus-host-disease: a systematic review and future directions","volume":"138","author":"Hm","year":"2021","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.gastro.2020.07.013","article-title":"Fecal microbiota transplantation reduces symptoms in some patients with irritable bowel syndrome with predominant abdominal bloating: short- and long-term results from a placebo-controlled randomized trial","volume":"160","author":"Holvoet","year":"2021","journal-title":"Gastroenterology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e0210016","DOI":"10.1371\/journal.pone.0210016","article-title":"Fecal microbiota transplantation for treatment of recurrent C. difficile infection: an updated randomized controlled trial meta-analysis","volume":"14","author":"Hui","year":"2019","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13643-018-0695-8","article-title":"An introduction to overviews of reviews: planning a relevant research question and objective for an overview","volume":"7","author":"Hunt","year":"2018","journal-title":"Syst. Rev."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/apt.15330","article-title":"Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome","volume":"50","author":"Ianiro","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1177\/2050640618780762","article-title":"Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: a systematic review and meta-analysis","volume":"6","author":"Ianiro","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13073-021-00828-8","article-title":"Highly elevated polygenic risk scores are better predictors of myocardial infarction risk early in life than later","volume":"13","author":"Isgut","year":"2021","journal-title":"Genome Med."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12916-016-0698-z","article-title":"Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"14","author":"Jalanka","year":"2016","journal-title":"BMC Med."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12866-018-1197-5","article-title":"Disbiome database: linking the microbiome to disease","volume":"18","author":"Janssens","year":"2018","journal-title":"BMC Microbiol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrd2505","article-title":"Gut microbiota: a potential new territory for drug targeting","volume":"7","author":"Jia","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"609","DOI":"10.7326\/M16-0271","article-title":"Effect of Fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial","volume":"165","author":"Kelly","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/apt.15116","article-title":"Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation","volume":"49","author":"Lai","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S2468-1253(21)00303-4","article-title":"Roles of the gut virome and mycobiome in faecal microbiota transplantation","volume":"7","author":"Lam","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2022.01.017","article-title":"Mucosal fungi promote gut barrier function and social behavior via type 17 immunity","volume":"185","author":"Leonardi","year":"2022","journal-title":"Cells"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/apt.13492","article-title":"Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection","volume":"43","author":"Li","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.11969\/j.issn.1673-548X.2016.06.031","article-title":"Fecal microbiota transplantation for the treatment of inflammatory bowel disease: a systematic review and a meta-analysis of single rate","volume":"45","author":"Lin","year":"2016","journal-title":"J. Med. Res."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6612970","article-title":"Fecal microbiota transplantation as therapy for treatment of active ulcerative colitis: a systematic review and meta-analysis","volume":"2021","author":"Liu","year":"2021","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.dld.2017.01.142","article-title":"Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: a systematic review and meta-analysis","volume":"49","author":"Liu","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1016\/j.cell.2022.06.040","article-title":"Single-cell approaches in human microbiome research","volume":"185","author":"Llor\u00e9ns-Rico","year":"2022","journal-title":"Cells"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/pathogens11070781","article-title":"Gut microbiota composition associated with Clostridioides difficile colonization and infection","volume":"11","author":"Martinez","year":"2022","journal-title":"Pathogens"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5694\/mja17.00295","article-title":"Faecal microbiota transplantation for Clostridium difficile associated diarrhoea: a systematic review of randomised controlled trials","volume":"207","author":"Moayyedi","year":"2017","journal-title":"Med. J. Aust."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1136\/gutjnl-2018-316818","article-title":"The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines","volume":"67","author":"Mullish","year":"2018","journal-title":"Gut"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1177\/2050640619866990","article-title":"Fecal microbiota transplantation in irritable bowel syndrome: a systematic review and meta-analysis","volume":"7","author":"Myneedu","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"ref50","volume-title":"Clostridioides difficile","year":"2021"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"l2368","DOI":"10.1136\/bmj.l2368","article-title":"Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies","volume":"366","author":"Neuenschwander","year":"2019","journal-title":"BMJ"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10620-020-06090-z","article-title":"Microbial-based and microbial-targeted therapies for inflammatory bowel diseases","volume":"65","author":"Oka","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1053\/j.gastro.2016.11.010","article-title":"Efficacy of sterile Fecal filtrate transfer for treating patients with Clostridium difficile infection","volume":"152","author":"Ott","year":"2017","journal-title":"Gastroenterology"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","article-title":"Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Paramsothy","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/lam.13486","article-title":"Effectiveness of fecal microbiota transplant for the treatment of Clostridioides difficile diarrhea: a systematic review and meta-analysis","volume":"73","author":"Pomares Bascu\u00f1ana","year":"2021","journal-title":"Lett. Appl. Microbiol."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2020.06.018","article-title":"Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials","volume":"83","author":"Proen\u00e7a","year":"2020","journal-title":"Nutr. Res."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/19490976.2017.1353848","article-title":"The risk of inflammatory bowel disease flares after fecal microbiota transplantation: systematic review and meta-analysis","volume":"8","author":"Qazi","year":"2017","journal-title":"Gut Microbes"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/apt.14201","article-title":"Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection","volume":"46","author":"Quraishi","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10620-020-06185-7","article-title":"Fecal microbiota transplantation (FMT) with colonoscopy is superior to enema and nasogastric tube while comparable to capsule for the treatment of recurrent Clostridioides difficile infection: a systematic review and meta-analysis","volume":"66","author":"Ramai","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"150","DOI":"10.20524\/aog.2022.0695","article-title":"Adverse events in fecal microbiota transplantation: a systematic review and meta-analysis","volume":"35","author":"Rapoport","year":"2022","journal-title":"Ann. Gastroenterol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1177\/2050640619854587","article-title":"A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection","volume":"7","author":"Rokkas","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.transproceed.2015.12.040","article-title":"Efficacy and mechanisms of action of Fecal microbiota transplantation in ulcerative colitis: pitfalls and promises from a first meta-analysis","volume":"50","author":"Scaldaferri","year":"2018","journal-title":"Transplant. Proc."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/MCG.0000000000001610","article-title":"Fecal microbiota transplantation and medical therapy for Clostridium difficile infection meta-analysis of randomized controlled trials","volume":"56","author":"Singh","year":"2021","journal-title":"J. Clin. Gastroenterol."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/jcag\/gwab023","article-title":"Fecal microbiota transplantation for severe or fulminant Clostridioides difficile infection: systematic review and meta-analysis","volume":"5","author":"Song","year":"2022","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41579-021-00667-9","article-title":"Microbiome-based therapeutics","volume":"20","author":"Sorbara","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cmi.2019.01.005","article-title":"ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant gram-negative bacteria carriers","volume":"25","author":"Tacconelli","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00384-020-03599-7","article-title":"Clinical remission of ulcerative colitis after different modes of faecal microbiota transplantation: a meta-analysis","volume":"35","author":"Tang","year":"2020","journal-title":"Int. J. Color. Dis."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/cid\/ciy721","article-title":"Low cure rates in controlled trials of Fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review and meta-analysis","volume":"68","author":"Tariq","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/MCG.0000000000001633","article-title":"Outcomes of Fecal microbiota transplantation for C. difficile infection in inflammatory bowel disease: a systematic review and meta-analysis","volume":"57","author":"Tariq","year":"2021","journal-title":"J. Clin. Gastroenterol."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jhin.2019.03.010","article-title":"Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut: a systematic review and meta-analysis","volume":"102","author":"Tavoukjian","year":"2019","journal-title":"J. Hosp. Infect."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s10620-021-06908-4","article-title":"Systematic review with meta-analysis: Fecal microbiota transplantation for severe or fulminant Clostridioides difficile","volume":"67","author":"Tixier","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1038\/s41467-021-23460-x","article-title":"Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis","volume":"12","author":"Van der Lelie","year":"2021","journal-title":"Nat. Commun."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27","author":"Van Prehn","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"G310","DOI":"10.1152\/ajpgi.00282.2013","article-title":"Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection","volume":"306","author":"Weingarden","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"24","DOI":"10.13764\/j.cnki.ncdm.2021.04.005","article-title":"Fecal microbiota transplantation for Crohn\u2019s disease: a meta-analysis","volume":"61","author":"Wu","year":"2021","journal-title":"Beijing Biomed. Eng."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.14309\/ajg.0000000000000198","article-title":"Efficacy of Fecal microbiota transplantation in irritable bowel syndrome: a systematic review and meta-analysis","volume":"114","author":"Xu","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"765","DOI":"10.13381\/j.cnki.cjm.202107004","article-title":"Efficacy and safety of fresh fecal microbiota transplantation for treatment of recurrent Clostridium difficile infection: a meta-analysis","volume":"33","author":"Yang","year":"2021","journal-title":"Chin. J. Microecol."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"9804014","DOI":"10.34133\/2022\/9804014","article-title":"Material engineering in gut microbiome and human health","volume":"2022","author":"Yang","year":"2022","journal-title":"Research (Wash D C)"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3969\/j.issn.1008-7125.2020.10.004","article-title":"Efficacy of Fecal microbiota transplantation for treating Crohn 's disease: a systematic review and meta-analysis of single rate","volume":"25","author":"Ye","year":"2020","journal-title":"Chin. J. Microecol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.21037\/atm-20-4243","article-title":"Egg consumption and health outcomes: a global evidence mapping based on an overview of systematic reviews","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/1751-2980.12933","article-title":"Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: a systematic review and meta-analysis","volume":"21","author":"Zhao","year":"2020","journal-title":"J. Dig. Dis."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1053\/j.gastro.2020.06.048","article-title":"Alterations in Fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge","volume":"159","author":"Zuo","year":"2020","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1286429\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T06:27:11Z","timestamp":1698992831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1286429\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":84,"alternative-id":["10.3389\/fmicb.2023.1286429"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1286429","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"article-number":"1286429"}}